Chylomicron remnant physiology

Jump to navigation Jump to search

Chylomicron Remnant Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Biochemistry

Physiology

Clinical Correlation

High Chylomicron Remnant

Definition
Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications

Low Chylomicron Remnant

Definition
Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

Chylomicron remnant physiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chylomicron remnant physiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chylomicron remnant physiology

CDC on Chylomicron remnant physiology

Chylomicron remnant physiology in the news

Blogs on Chylomicron remnant physiology

Directions to Hospitals Treating Chylomicron remnant

Risk calculators and risk factors for Chylomicron remnant physiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Once triglyceride stores are distributed, the chylomicron returns APOC2 to the HDL (but keeps APOE) and thus, becomes a chylomicron remnant. APOB48 and APOE are important to identify the chylomicron remnant in the liver for endocytosis and breakdown.

References